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ABSTRACT
Binding of the internal ribosome entry site (IRES) of
the hepatitis C virus (HCV) RNA to the eIF-free 40S
ribosomal subunit is the first step of initiation of
translation of the viral RNA. Hairpins IIId and IIIe
comprising 253–302 nt of the IRES are known to be
essentialforbindingtothe40Ssubunit.Herewehave
examinedthemolecularenvironmentoftheHCVIRES
in its binary complex with the human 40S ribosomal
subunit. For this purpose, two RNA derivatives were
used that bore a photoactivatable perfluorophenyl
azide cross-linker. In one derivative the cross-linker
was at the nucleotide A296 in hairpin IIIe, and in the
other at G87 in domain II. Site-specific introduction
of the cross-linker was performed using alkylating
derivatives of oligodeoxyribonucleotides comple-
mentary to the target RNA sequences. No cross-links
with the rRNA were detected with either RNA derivat-
ive. The RNA with the photoactivatable group at A296
cross-linked to proteins identified as S5 and S16
(major) and p40 and S3a (minor), while no cross-links
with proteins were detected with RNA modified at
G87. The results obtained indicate that hairpin IIIe is
locatedonthesolventsideofthe40Ssubunitheadon
a site opposite the beak.
INTRODUCTION
It is now well established that initiation of protein synthesis
can occur via two alternative mechanisms. The conventional
cap-dependent mechanism is typically used by capped
eukaryotic cellular mRNAs and is mediated by a number of
initiation factors that taken together are responsible for the
ultimate correct positioning of the start AUG codon on the 40S
ribosomal P site (1,2). The alternative pathway called internal
translation initiation is based on the cap-independent recruit-
ment of the so-called internal ribosomal entry site (IRES), a
speciﬁcally structured RNA segment in the 50-untranslated
region (50-UTR) upstream the initiation AUG codon. This
RNA segment is responsible for positioning of the start
AUG codon in the P site mediated by a reduced number of
initiation factors as compared to the conventional mechanism,
or in several cases even without any initiation factors.
A number of viral and some eukaryotic cellular mRNAs
contain such IRES elements (3).
Hepatitis C virus (HCV) is one of the most dangerous
human pathogens that can lead to cyrrosis, hepatocellular
carcinoma and other damages of the liver. The genomic
RNA of HCV contains an IRES element possessing a complex
secondary (Figure 1a) and tertiary structure essential for
effective translation of the viral RNA (3,4). This RNA is
able to form a stable binary complex with the 40S ribosomal
subunit providing the positioning of the initiation AUG codon
at or close to the P site without any initiation factors (5).
Interaction of the HCV IRES with the 40S subunit has been
extensively studied using various approaches. By direct ultra-
violet (UV)-induced cross-linking, it was reported that in the
binary complex with the 40S subunit IRES cross-links with
only one protein. This protein was initially identiﬁed as S9 (5),
but another group then reported that it was actually S5 (6).
At the same time, data obtained by cryo-electron microscopy
(cryo-EM) (7) pointed to multiple contacts of the IRES with
the 40S subunit. The footprinting (8) and the ﬁngerprinting (9)
results also indicated that the area of IRES interaction with the
40S ribosomal subunit is not restricted to one protein. HCV
IRES with uridines randomly substituted by 4-thiouridines
cross-linked to proteins S2, S3, S10, S15, S16, S18 and
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Moreover, it was observed that the ribosomal proteins S3,
S5, S7, S18 and p40 can bind to the HCV IRES out of the
ribosome in cell extracts (11). However, the relationships
between these interactions and initiation of HCV RNA
translation are as yet not clear.
Data concerning the involvement of large structural
domains of the HCV IRES in particular steps of initiation
of viral RNA translation have been reported [e.g. see (12–
14)]. Recently, a revised model of this process was suggested
(15) according to which the HCV IRES ﬁrst binds to the 40S
subunit to form the binary complex, and only the basal portion
of domain III (mainly hairpins IIId and IIIe) is required for
binding. Thereafter, eIF3 and the ternary complex (eIF2 Met-
tRNAi
Met  GTP) assemble to form a 48S preinitiation complex
dependent on both the base of domain III and a proper
initiation codon. In addition, at this step subdomain IIIb is
involved in eIF3 binding. Subsequent formation of the 80S
complex is dependent on GTP hydrolysis and 60S subunit
joining, and is regulated by domains II and IIIb. It alsoremains
unclear how particular structural elements of the HCV IRES
interact with the 40S subunit and what ribosomal components
are involved in the particular interactions at the various steps
of translation initiation. The molecular environment of the
HCV IRES domains on the ribosome may be studied with
RNA derivatives bearing a cross-linker at speciﬁc locations.
Such derivatives could be obtained by site-speciﬁc alkylation
of an RNA with [4-(N-2-chloroethyl-N-methylamino)benzyl]-
phosphoramide derivatives of oligodeoxyribonucleotides
complementary to a sequence adjacent to the target
site. The phosphoramide bond in the covalent adducts formed
would then be hydrolysed under mild acidic conditions,
and aryl azide groups would be selectively introduced
at the benzylamine groups liberated after hydrolysis.
Initially, this approach was elaborated for the introduction
of cross-linkers into speciﬁc sites of tRNAs (16); later
this approach was shown to also be applicable to longer (up
to 300 nt long) RNAs possessing complex secondary
structure (17).
Here, we present a study of the environment of subdomain
IIIe of the HCV IRES on the human 40S ribosomal subunit in
the binary complex that is formed as the ﬁrst step of translation
initiation of the HCV IRES. Hairpin IIIe belongs to the base of
domain III, which is involved in binary complex formation
(see above). For this purpose, the respective RNA transcript
bearing a photoactivatable perﬂuorophenyl azide group at the
nucleotide A296 in subdomain IIIe was used. In parallel,
control experiments were carried out with a derivative of
HCV RNA with the cross-linker at G87 in domain II which
is involved only in the late stage of the initiation of HCV IRES
translation and is not required for binding of the IRES to the
40S subunit (see above). The identiﬁcation of cross-linked
proteins was based on their electrophoretic analysis by one
and two dimensional (1,2D) PAGE, a methodology widely
used to identify ribosomal proteins cross-linked with various
components of the translational machinery, e.g. with HCV
IRES (10), and with mRNA analogues (18).
MATERIALS AND METHODS
Materials
Acrylamide, N,N0-methylene-bis-acrylamide and urea were
purchased from AppliChem, ribonucleoside triphosphates
and avidin agarose were from Sigma, biotin-16-uridine
triphosphate from Roche, Sephadex G-75 from Pharmacia,
AMV reverse transcriptase from Life Science and T7 RNA
polymerase from NEB. T4 polynucleotide kinase was pre-
pared in the Laboratory of Bioorganic Chemistry of enzymes
at the Institute of Chemical Biology and Fundamental
Medicine SB RAS; DNA oligomers complementary to deﬁnite
sequences of the HCV IRES were synthesized in the
Laboratory of Medical Chemistry, [a-
32P]GTP (1 mCi/
nmol) was synthesized in the Laboratory of Biotechnological
Chemistry, 4-(N-2-chloroethyl-N-methylamino)benzylamine
(ClRCH2NH2) and N-oxysuccinimide ester of
4-azidotetraﬂuorobenzoic acid were kind gifts from
Dr T.M. Ivanova of this Institute.
Labelled HCV IRES RNA was obtained by in vitro
transcription of plasmid pXL40-372.NS0 (19) linearized by
digestion with BamH1 (‘Fermentas’, Lietuva) as described
(14). The speciﬁc radioactivity of the RNA transcript at the
time of isolation was typically about 25 000 c.p.m./pmol.
Slightly labelled biotinylayted HCV IRES was obtained
as described above but adding 0.2 mM biotin-16-uridine
triphosphate to the reaction mixture and using 5 mCi instead
of 0.1 mCi [a-
32P]GTP. The speciﬁc radioactivity of the
RNA transcript at the time of isolation was typically about
1000 c.p.m./pmol.
4-(N-2-chloroethyl-N-methylamino)benzyl-50-phosphoramides
of oligodeoxyribonucleotides were synthesized and puriﬁed
as described (14).
Site-speciﬁc modiﬁcation of HCV IRES RNA was carried
out as described (14) starting with 300 pmol of the RNA
transcript.
Nucleotides of the IRES RNA cross-linked to the
oligodeoxyribonucleotide derivatives were determined by
reverse transcription as described (20).
To hydrolyse the phosphoramide bond in the deoxyribonuc-
leotide derivatives attached to the RNA, the covalent RNA
adducts were incubated in 300 mM NaOAc (pH 4.1) at 50 C
for 6 h. The reaction was stopped by ethanol precipitation; the
modiﬁed RNA was puriﬁed by 8% denaturing PAGE and
eluted from the gel as described above. The mobility in
the gel of the resulting modiﬁed RNA was the same as that
of the unmodiﬁed IRES RNA and was evidence of the removal
the oligodeoxyribonucleotide moiety and liberation of the
RCH2NH2 group attached to the RNA.
Selective introduction of perﬂuorophenyl azide at the
RCH2NH2 group attached to the RNA. RNA obtained after
Figure 1. (a) Structural organization of the HCV IRES (3). RNA sequences complementary to deoxy oligomers used for the site-specific modification of the
HCVIRESare markedwithhardlines.Asequencecomplementaryto thehelperoligomerusedtogetherwiththealkylatingderivativein hairpinIIIeismarkedwith
dotted line. Arrows indicate 50-termini of the oligomers derivatized with the alkylating groups. Nucleotides of the HCV IRES cross-linked to the oligonucleotide
derivativesareshaded.(b)Schemeofsite-specificintroductionofaphotoactivatablegroupintospecificRNAsitesbasedonthecomplementary-addressedalkylation
of the RNA with [4-(N-2-chloroethyl-N-methylamino)benzyl]-phosphoramides of oligodeoxyribonucleotides.
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50 ml of 50 mM HEPES-KOH (pH 9.0) and mixed with an
equal volume of 20 mM N-oxysuccinimide ester of
4-azidotetraﬂuorobenzoic acid in dimethyl sulfoxide
(DMSO). The mixture was incubated in the dark at room
temperature for 90 min, and low molecular mass organic
compounds were then extracted with 3 volumes of ether.
The modiﬁed RNA was precipitated from the water phase
with ethanol, reprecipitated twice with ethanol from 50%
DMSO in water, dissolved in water and stored in liquid
nitrogen until used in cross-linking experiments.
Ribosomes, ribosomal complexes and cross-linking
procedures
Ribosomes. 40S ribosomal subunits with intact rRNA were
isolated from unfrozen human placenta as indicated (21).
Prior to use, the subunits were re-activated by incubation
in binding buffer A [20 mM Tris–HCl (pH 7.5), 100 mM
KCl, 2.5 mM MgCl2 and 0.25 mM spermidine] at 37 C for
10 min.
Ribosomal complexes. Binary complexes of HCV IRES and
40S subunits were obtained by incubating the subunits (1.5 ·
10
 6 M if not speciﬁed otherwise) with IRES (0.5 · 10
 6 Mi f
not speciﬁed otherwise) in buffer A as described (14). The
extent of binding of the 50-
32P-labelled RNAs to 40S subunits
was examined by nitrocellulose ﬁltration assay using alkali
pretreated ﬁlters as described (22).
Cross-linking. UV-irradiation of the complexes was carried
out according to (18). The distribution of the cross-linked
labelled IRES between the rRNA and proteins was examined
by centrifugation in a 5–20% sucrose density gradient in the
presence of SDS and EDTA as described (23).
Isolationandanalysisofribosomalproteinscross-linked
to biotinylated IRES RNAs
Irradiated 40S subunits were ethanol precipitated and
dissolved in 20 ml of 20 mM Tris–HCl (pH 7.5) containing
1 mM EDTA. The mixture was supplied with 20 mlo fa n
avidin agarose suspension, incubated at 37 C for 2 h under
stirring, and the avidin agarose with bound biotinylated RNA
was pelleted by centrifugation. To destroy all possible RNA–
protein complexes, the pellet was incubated with 40 mlo f6M
ureacontaining1%SDS at50 Cfor15min, the avidinagarose
was pelleted by centrifugation and the supernatant containing
proteins not covalently bound to the IRES was discarded. The
pellet was washed three times with 40 ml of the same solution
and three times with 100 ml of water. To hydrolyse the RNA
bound to avidin agarose, the pellet was mixed with 10 mlo f
20 mM Tris–HCl (pH 7.5) containing 1 mM EDTA and 10 mg
RNase A and incubated at 37 C for 3 h. The avidin agarose
was then removed by centrifugation and to the supernatant
were added 10 ml of buffer containing 120 mM of Tris–HCl
(pH 7.5), 4% SDS, 40% glycerol, 0.1% bromphenol blue and
2% 2-mercaptoethanol for the subsequent analysis of the pro-
teins by a standard one dimensional (1D) electrophoresis in a
150 · 180 · 0.75 mm polyacrylamide gel containing SDS
(SDS–PAGE); the gel was silver stained and dried. Total
human 40S protein isolated as indicated (21) was used for
the marker lane.
Isolationandanalysisofribosomalproteinscross-linked
to labelled IRES RNAs
Irradiated 40S subunits were precipitated with ethanol and
dissolved in 30 ml of water, supplied with 1 mlo f
2-mercaptoethanol, 90 ml of 8 M urea and 3.6 ml of 0.1 M
EDTA-NaOH (pH 7.5) and incubated at 37 C for 5 min to
dissociate the subunits into rRNA and proteins. The RNA was
completely hydrolysed by addition of 3.2 ml of 0.7 M sodium
citrate (pH 5.0), and 3 ml of RNAse A (10 mg/ml) followed by
the incubation at 37 C for 1 h. The proteins were precipitated
by cold acetone; after centrifugation the pellet was dissolved
in 100 ml of 6 M guanidine hydrochloride containing 0.1%
of 2-mercaptoethanol and incubated at 37 C for 30 min to
completely denature the proteins. The proteins were separated
from thelabelled short oligoribonucleotidesby gelﬁltrationon
a 2 ml Sephadex G-50 superﬁne column; elution was with 6 M
guanidine hydrochloride, 25 mM Tris–HCl (pH 7.5), 0.1 mM
EDTA, 25 mM NaCl and 5% ethanol. Fractions of 100 ml were
collected and their radioactivity was measured by Cherenkoff
counting. Typically, labelled proteins were eluted in fractions
3–6 corresponding to the void volume of the column. After
1–2 intermediate fractions, radioactivity strongly increased
indicating elution of oligonucleotides. The proteins were pre-
cipitated from the respective fractions by addition of 9 vol of
cold ethanol. Each pellet was washed with 200 ml of 90%
ethanol, dried and dissolved in 7 ml of 8 M urea for subsequent
analysis by 2D PAGE in an alkaline-SDS system (24). The
separation in the ﬁrst dimension was in an 8% gel containing 8
M urea at pH 8.6; in the second dimension, separation was in a
12.5% gel containing SDS at pH 6.7. To identify the cross-
linked proteins, the radioautograms were superimposed on the
respective stained gels and the positions of the radioactive
bands with respect to those of unmodiﬁed proteins were
determined.
RESULTS
Site-specific introduction of photoactivatable groups
into the HCV IRES
The scheme for the introduction of a photoactivatable group in
selected positions of RNA transcripts containing the
complete 50-UTR of HCV RNA is presented in Figure 1b.
Site-speciﬁc alkylation of the RNA was performed using
4-(N-2-chloroethyl-N-methylamino)benzyl-50-phosphoramides
of oligodeoxyribonucleotides complementary to positions
277–295 and 71–87 of the HCV IRES. Sequence 277–295
is located in the region of the stem–loop IIIe (Figure 1a)
which together with the hairpin IIId plays critical role in
the formation of the binary complex of the HCV IRES with
40S subunits and is the object of the present study. In contrast,
sequence 71–87 belongs to the apical loop of domain II
(Figure 1a), which is not essential for binding to 40S subunits
and the corresponding IRES derivative bearing the
cross-linker in domain II was used here as control.
Alkylation of the IRES was carried out at 25 C for a period
sufﬁciently long to almost completely convert the
2-chloroethylamine group to the ethylene immonium cation,
which is an active intermediate (25). The ClRCH2NH- moiety
coupled to the 50-terminal nucleotide of the oligonucleotide is
2030 Nucleic Acids Research, 2006, Vol. 34, No. 7known to cross-link to the nucleotide base paired with it or to
the neighboring unpaired nucleotide (17,26).Any RNA base at
such positions may be cross-linked with the exception for
uracil, which is unable to react with aromatic 2-chloroethyl
amines under the conditions used (27).
To increase the yield of the covalent adduct with the
derivative of the oligonucleotide complementary to positions
277–295, a helper oligomer complementary to positions
259–276 was used that forms a tandem with the oligomer
bearing the alkylating group (Figure 1a) (14).
The covalent adducts resulting from IRES alkylation with
the oligonucleotide derivatives were separated from unmodi-
ﬁed RNA by denaturing PAGE on an 8% gel (the respective
electrophoregrams are not shown). The extents of alkylation
with the derivatives of oligomers complementary to positions
71–87 and 277–295 were 0.4 and 0.6 mol of oligomer residues
per mol of RNA. In our previous study (14) we showed that the
cross-linked oligomers actually form heteroduplexes with the
respective complementary RNA sequences. Cross-linked
nucleotides of the IRES were identiﬁed here by reverse tran-
scription. Primer extension leads to a stop or pause at the
cross-linked rRNA nucleotide. The cross-linking site is
generally assumed to be the nucleotide 50 of the primer
extension stop site. Therefore, cross-linked nucleotides of
the HCV IRES should be A296 (Figure 2a, lane 1) and
U86 (Figure 2b, lane 2). However, taking into account that
uracil could not be alkylated under the conditions used (see
above), in the latter case the cross-linked nucleotide was G87
rather than U86. The reverse transcriptase most probably
pauses at G87 (this is a pause rather than stop since the N7
of the guanine is not involved in Watson–Crick base pairing).
To introduce photoactivatable moieties at the modiﬁed
RNA nucleotides, the phosphoramide bond in the covalent
adducts was hydrolysed under mild acidic conditions (pH 4.1)
that resulted in the release of the aliphatic amino group
-RCH2NH2 linked to the RNA. The modiﬁed IRES RNAs
were puriﬁed by denaturing PAGE in an 8% gel and the
-RCH2NH2 moieties were selectively derivatized by treatment
with the N-oxysuccinimide ester of 4-azidotetraﬂuorobenzoic
acid. Thus, HCV IRES bearing photoactivatable groups at
nucleotides A296 (designated RNA I) and G87 (designated
RNA II) were obtained. These RNAs were used in the
cross-linking experiments with human 40S ribosomal
subunits. IRES RNAs (designated RNA K) treated under
identical conditions but without addition of alkylating
derivatives of oligodeoxyribonucleotides served as controls.
Binding and cross-linking of photoactivatable HCV
IRES derivatives to 40S subunits
Filter retention assays revealed that afﬁnities of RNA I, RNA
II and RNA K for human 40S subunits are similar to each other
and do not signiﬁcantly differ from that of the untreated IRES
(Figure 2c). For the cross-linking experiments, saturating con-
centration of 40S subunits was used. To obtain the cross-links,
the binary complexes of RNA I and RNA II with 40S subunits
were irradiated with mild UV light (wavelength >280 nm).
The subsequent analysis of the distribution of the radioactive
label between the rRNA and proteins by centrifugation
in sucrose density gradients containing SDS and EDTA did
not reveal radioactivity in the fractions containing 18S rRNA
(the respective sedimentation proﬁles are not presented).
Radioactivity was found only in the top fractions containing
proteins and the IRES not cross-linked to ribosomal compo-
nents. This indicated that both RNA I and RNA II did not
cross-link to the rRNA.
Identification of ribosomal components cross-linked to
photoactivatable HCV IRES derivatives
To identify the ribosomal proteins cross-linked to the deriv-
atives of the IRES, two different approaches were used. The
ﬁrst approach was based on the application of the slightly
labelled biotinylated RNA transcripts. After irradiation of
the binary complexes of RNA I, RNA II and RNA K with
40S subunits, the RNA–protein cross-links were isolated by
Figure 2. Identification of sites of cross-linking of oligonucleotide derivatives
to the HCV IRES by reverse transcription and binding properties of the HCV
IRES derivatives. Extension of 50-
32P-labelled primers complementary to the
HCV IRES sequences 331–350 (a) and 103–120 (b). Lanes 1, 2 and K, primer
extension on RNA I, RNA II and RNA K, respectively. Lanes U, G, C, A,
sequencingofHCVIRES.Positionsofthereversetranscriptionstopscausedby
the cross-links are indicated by arrows. (c) Isotherms of binding of the HCV
IRES and its derivatives (1.0 · 10
 7 M) to 40S subunits in a buffer containing
100 mM K
+, 2.5 mM Mg
2+, 0.25 mM spermidine at 30 C. Solid lines 1 (filled
squares)and3(filleddiamonds),RNAIIandRNAI,respectively;dottedline2
(open triangles), RNA K; open circles without line correspond to untreated
HCV IRES. Relative error was in average about 10%.
Nucleic Acids Research, 2006, Vol. 34, No. 7 2031afﬁnity chromatography on avidin agarose. The RNA cross-
linked to the proteins was hydrolysed by RNase A and the
proteins released from the adsorbent were resolved by 1D
SDS–PAGE followed by silver staining. The results are
presented in Figure 3a. In the experiments with RNA I,
three bands x, y and z are visible that correspond to the
proteins cross-linked to this RNA (lane 1). This cross-linking
is speciﬁc since no protein bands are seen with RNA II (lane 2)
or with RNA K (lane K). To identify the proteins cross-linked
to RNA I, one should take into account the fact that the
trinucleotide fragment of the RNA remains attached to
these proteins after complete hydrolysis with RNase A, as
may be easily inferred from the sequence of the HCV IRES
around nucleotide A296 carrying the cross-linker (Figure 1a).
Such a fragment does not noticeably affect the electrophoretic
mobility of ribosomal proteins with molecular masses of
25 kDa and higher (18). The positions of the bands ‘x’ and
‘y’ in lane 1 correspond exactly to those of proteins p40 and
S2/S3a, respectively, in lane TP40 (Figure 3a). Thus, bands ‘x’
and ‘y’ may be unambiguously assigned to proteins p40 and
S2/S3a cross-linked to RNA I. As for ribosomal proteins with
lower molecular masses, the cross-linked nucleotide residues
slightly but noticeably retard the electrophoretic mobilities of
proteins as compared to those of the unmodiﬁed proteins (18).
Therefore, band ‘z’ in lane 1 whose position exactly coincides
with that of protein S7 in lane TP40 (Figure 3a) should be
assigned to the cross-linked S5 rather than the S7 protein
(neighboring S9 is not a candidate for the cross-linked protein
since product ‘z’ migrates even faster than unmodiﬁed S9
in lane TP40). Thus, 1D SDS–PAGE made it possible to
identify proteins p40, S2/S3a and S5 as cross-linked to
RNA I. At the same time, this set may be incomplete since
the strong band corresponding to RNase A could mask bands
of other cross-linked proteins, such as S16, S19, S26 and less
probably, S20, S14, S15aand S23(Figure 3a).To examine this
possibility, we performed the 1D SDS–PAGE analysis of the
proteins cross-linked to a highly labelled RNA I. This analysis
(Figure3b)revealedfour mainradioactivebands; the positions
oftheupper threebandsarecompatiblewiththoseoftheabove
mentioned cross-linked proteins p40, S2/S3a and S5.
The lower and most intense band is in the position that was
occupied by RNase A in Figure 3a. These four intense bands
are seen in the background of several weakbands that were not
revealed in the experiment presented in Figure 3a. Their
origin is not clear and hence their assignment was not done
in this work.
To unambiguously identify cross-linked protein(s) migrat-
ing as RNase A and that corresponding to band ‘y’ (S2/S3a)
in Figure 3a, we resolved the proteins cross-linked to the
highly labelled RNA I by 2D PAGE under alkaline conditions
in the ﬁrst dimension, and in a slightly acidic gel containing
SDS (‘basic-SDS’ system) in the second dimension. This
system does not allow detection of proteins p40 and S5 that
do not enter the gel in the ﬁrst dimension, but these proteins
were already unambiguously identiﬁed by SDS–PAGE (see
the text above and Figure 3a). On the other hand, the
basic-SDS system is the best to resolve candidate proteins
S14, S15a, S16, S19, S20, S23 and S26 (see above) and to
make a choice between S2 and S3a. To avoid possible effects
caused by unspeciﬁc binding of proteins with short labelled
oligoribonucleotides resulting from hydrolysis of RNA
with RNase A, the proteins were separated from the oligonuc-
leotides by gel ﬁltration under strongly denaturing conditions
(6 M guanidine chloride) prior to the electrophoretic analysis.
The 2D PAGE separation revealed one major and several
minor radioactive spots (Figure 4a). It is known that in the
basic-SDS system short cross-linked oligonucleotides detect-
ably retard protein mobility almost exclusively in the ﬁrst
dimension (18). Consequently, the radioactive spot of the
cross-linked protein should be somewhat shifted to the left
of the respective stained spot of the unmodiﬁed protein. The
only stained spot that is adjacent to, and to the right of the
(a) (b)
Figure 3. Analysis of 40S ribosomal proteins cross-linked to the derivatives of HCV IRES by 1D PAGE in the presence of SDS. (a) Silver stained gel obtained in
experiments with biotinylated IRES derivatives. Lanes 1, 2 and K correspond to the proteins isolated from the irradiated complexes of 40S subunits with RNA I,
RNAIIandRNAK,respectively.LaneTP40correspondstotheelectrophoregramoftotal40Sprotein;positionsofthe40Sribosomalproteinsareindicated(35,36).
(b) Analysis of proteins cross-linked to labelled RNA I in the binary complex with the 40S subunit. Lane 1, Coomassie stained gel; lane 2, autoradiogram of
the gel.
2032 Nucleic Acids Research, 2006, Vol. 34, No. 7major radioactive spot, is S13/S16; S25 is also to the right but
below the radioactive spot (Figure 4b). Therefore, the cross-
linked protein is S13/S16 rather than S25. Moreover, cross-
linking to protein S25 may be excluded as well since it does
not belong to the list of candidate proteins whose bands could
be masked by the RNase A band in the SDS–polyacrylamide
gel (see above).For the same reason, proteinS13 shouldnot be
regarded as cross-linked. Therefore, the major radioactive
band in the 2D polyacylamide gel corresponds to the cross-
linked protein S16. A minor radioactive spot in the upper part
of the electrophoregram clearly corresponds to the cross-
linked protein S3/S3a (Figure 4b). Thus, combining the sets
of proteins identiﬁed by SDS–PAGE (p40, S2/S3a and S5) and
by 2D PAGE (S3/S3a and S16), we conclude that the HCV
IRES with the perﬂuorophenyl azide modiﬁed nucleotide
A296 cross-links to proteins p40, S3a, S5 and S16 in the
binary complex with the 40S subunit. Of these proteins, S5
and S16 seem to be the preferred targets for cross-linking.
Proteins p40, S5 and S16 are homologous to prokaryotic
S2, S7 and S9, respectively (28), and S3a has no prokaryotic
counterpart (28).
DISCUSSION
Choice of sequences within the HCV IRES for the
site-specific introduction of perfluorophenyl azide
cross-linkers
Initially, derivatives of oligodeoxyribonucleotides comple-
mentary to speciﬁc sequences of the HCV IRES and bearing
an alkylating group at the terminal phosphate were applied to
obtain covalent adducts of the IRES with the deoxy oligomers.
The puriﬁed adducts have been then used to study the role of
the respective IRES sequences in the binding to 40S subunits
(14). Afﬁnity of 40S subunits for the HCV IRES covalent
adducts bearing deoxy oligomers complementary to sequences
in hairpin IIId and IIIe was drastically lower than that for the
unmodiﬁed IRES. The lowest afﬁnity was observed for the
adduct with the deoxy oligomer complementary to positions
277–295. In contrast, attachment of a deoxy oligomer com-
plementary to the sequence 71–87 in the apical loop of domain
II barely affected the afﬁnity of the IRES for the 40S subunits
(14). These results were in excellent agreement with other data
indicating that HCV IRES subdomains IIId and IIIe are the
main determinants for binding to 40S subunits and that domain
II is not required for the binding (12,13,15). Based on these
results, we chose alkylating derivatives of deoxy oligomers
complementary to the HCV IRES sequences 277–295 in hair-
pin IIIe and 71–87 in domain II to speciﬁcally introduce cross-
linkers into hairpin IIIe and domain II (Figure 1a). The former
oligomerwaschosensinceithadthestrongestinhibitoryeffect
on binding to 40S subunits, and the latter was used in parallel
as control. The perﬂuorophenyl azide employed here as cross-
linker makes it possible to reveal ribosomal components
located within 14 s of the speciﬁc HCV IRES nucleotide
bearing the cross-linker. It can modify both rRNA and proteins
as shown in studies with mRNA analogues bearing such cross-
linkers (18). The cross-linker introduced at either A296 or G87
did not interfere with binding of the respective HCV IRES
derivatives to the 40S subunit (Figure 2c). Thus, as opposed to
previous studies, we now present data in which the cross-
linked ribosomal components are attributed to speciﬁc sites
within the IRES.
Ribosomal components neighboring the HCV IRES on
the 40S subunit
Our ﬁnding that proteins p40, S3a, S5 and S16 lie close to
hairpin IIIe of the IRES provides new details, in addition to
the earlier cross-linking data (6,10), on the position of the
IRES on the 40S subunit. As reported earlier (10), we did
not ﬁnd any contacts of the HCV IRES with the 18S
rRNA. Two major proteins S5 and S16, had already been
identiﬁed as interacting with the HCV IRES (6,10). Protein
S5 was a target for UV (254 nm)-induced cross-linking with
the HCV IRES (6), and protein S16 was among the proteins
cross-linked to the IRES randomly substituted with
4-thiouridines (10). These proteins could not be attributed
earlier to the neighbors of the speciﬁc structural elements
of the IRES since the nucleotides involved in cross-linking
remained unknown. Cross-linking of the HCV IRES to pro-
teins p40 and S3a was detected here for the ﬁrst time. We
cannotexcludethatthesenewproteinswerecross-linkedtothe
IRES derivative due to the relatively long and ﬂexible per-
ﬂuoropohenyl azide used here but that these proteins could not
be reached by zero-length cross-linkers applied previously
(6,10). However, these two reports clearly indicate that
even zero-length cross-linking may result in quite different
patterns depending on whether a modiﬁed (thioU-substituted)
or non-modiﬁed RNA is used in the cross-linking studies.
For instance, no protein S5 was cross-linked to the thio(U)-
substituted HCV IRES (10) and no ribosomal proteins other
(a)
(b)
Figure4.Analysisofproteinscross-linkedtoRNAIinthebinarycomplexwith
the 40S subunit by 2D PAGE. (a), autoradiogram; (b), Coomassie stained gel,
thepositionsoftheproteinsareindicatedaccordingto(24).Thelocationsofthe
radioactive spots corresponding to the cross-linked proteins are indicated on
the stained gel by dotted lines. The cross-linked proteins are marked with an
asterisk (*).
Nucleic Acids Research, 2006, Vol. 34, No. 7 2033than S5were identiﬁedwhenusingunmodiﬁedHCVIRESand
UV cross-linking at 254 nm.
The cross-linking approach using dozens of reactive mRNA
analogues has been extensively applied for the study of the
human 80S ribosome mRNA binding channel [e.g. see (18, 23,
29, 30)].Thus it is worth comparing sets of proteins
cross-linked to mRNA analogues and to the HCV IRES deriv-
ative; proteins p40 and S16 have never been found to cross-
link with mRNA analogues and minor cross-linking to S5/S7
was detected when the cross-linker was in the ﬁrst (from the
50 end) position of the E site codon (30). Protein S3a cross-
linked to several mRNA analogues when a cross-linker
was in the same position or 3 nt upstream (29). We suggest
that the environment of hairpin IIIe of the HCV IRES on the
40S subunit overlaps to some extent with the mRNA
binding channel in the region of the E site. This overlap
seems not to be large and is probably limited to the
only S3a protein since protein S26, the main target for
cross-linking to perﬂuorophenyl azide modiﬁed nucleotides
of the E site codon and upstream (18), was not found in
this study.
Correlation of the cross-linking data with
cryo-EM models
Models of eukaryotic ribosomes at atomic resolution based on
X-ray crystallographic data are not yet available, so the cross-
linking data may be applied to models of eukaryotic ribosomes
created on the basis of cryo-EM data (7,31–33). The most
detailed studies on the structural organization of HCV IRES-
ribosome complexes were performed by cryo-EM of the bin-
ary complexes 40S HCV IRES (7) and 80S HCV IRES (33).
Figure 5a shows one of views representing the arrangement of
HCV IRES on the 40S subunit from rabbit reticulocytes
according to (7), however, the model does not show positions
ofribosomalproteins onthe subunitsurface.Proteins thathave
prokaryotic counterparts have been docked on the model of
yeast 40S subunits (31) (Figure 5b); in particular, this model
presents the locations of proteins S0A (a homologue of human
p40 in yeast), S5 and S16. One can see that all of them are
presumably located on the upper part of the solvent side of the
subunit. This is basically consistent with the cryo-EM model
of the HCV IRES location on the 40S subunit (7,33). Proteins
S5 and S16 come very close to each other on the head of the
subunit on the site opposite the beak near the exit tunnel for
mRNA (7,32). On the other hand, S0A (p40) is located
between the platform and the shoulder of the 40S subunit
relatively far from S5 and S16 (Figure 5b), at a distance of
about 50 s, meaning several times more than the maximum
length of the cross-linker (14 s). The latter seems to be incon-
sistent with cross-linking of these proteins with a photoactivat-
able groupatthe samenucleotide ofthe IRES boundtothe 40S
subunit. Possible reasons for this discrepancy are not fully
understood but several explanations for this phenomenon
can be put forward. First and the most probable reason is
that p40 is signiﬁcantly larger than its part homologous to
prokaryotic counterpart S2 that has been placed in the
cryo-EM map. Therefore, the distance between p40 and pro-
teins S5 and S16 might be signiﬁcantly smaller than 50 s.
Alternatively, a part of p40 may come close to these proteins
due to conformational alterations in the 40S subunit caused by
binding of the IRES (7) since the location of the proteins
mentioned has been proposed for the free 40S subunit (31).
Finally, the discrepancies in the distances between the ribo-
somal components estimated from ‘frozen’ static models and
those obtained by means of biochemical methods in solution
under near physiological conditions (in particular, cross-
linking) may reﬂect ﬂexibility of the ribosomes, e.g. dynamic
(a) (b)
bk
Figure5.(a)Surfacerepresentationofthe40SribosomalsubunitfromrabbitreticulocytesincomplexwiththeHCVIRES[adaptedfromref.(7)].Thecryo-EMmap
isshowninyellow.ThedifferencemapcorrespondingtotheHCVIRESissuperimposedandgiveninpurple.Theviewfromthesolventside.Thesuggestedlocation
ofhairpinsIIId/e/fisboxed.Asteriskshowtheproposedentry(right)andexit(left)sitesofthemRNA.(b)Structuralmodelofyeast40Sribosomalsubunitobtained
from cryo-EM data (solvent side view) [adapted from ref. (31)] in which locations of several ribosomal proteins that have prokaryotic counterparts are shown.
Abbreviationsused:rp,ribosomalprotein;h,head;bk,beak;sh,shoulder;pt,platform;b,body;lf,leftfoot;rf,rightfoot.Reddottedovalshowsthesuggestedlocation
of hairpin IIIe.
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(34). Although we cannot discriminate between these possib-
ilities, based on the cross-linking results, the most probable
site for the location of hairpin IIIe of the HCV IRES on the
static model of the eukaryotic 40S subunit can be suggested
and is presented in Figure 5b.
Protein S3a found here to be a minor target for cross-linking
to the IRES derivative has never been docked on cryo-EM
models of the eukaryotic 40S subunit since it has no proka-
ryotic counterparts (28). Data on cross-linking of the HCV
IRES derivatives and mRNA analogues to this protein [This
report and ref. (29)] now provide a reasonable idea on the
location of protein S3a on the ribosome. Most probably,
S3a is on the solvent side of the 40S subunit, on its upper
part aside from the beak close to the E site and mRNA exit
tunnel.
The lack of cross-linking to 40S subunits of the HCV IRES
with a photoactivatable group in G87 in domain II is in
agreement with the data discussed above that this domain
does not contribute to the afﬁnity of the IRES for the 40S
subunit. On the other hand, two cryo-EM reconstructions from
independent labs (7,33) show a very strong connection
between domain II and the head of the 40S at the position
of S5, which is powerful evidence for a direct interaction. But
in the earlier cross-linking report (10) in which HCV IRES
with zero-length cross-linker was applied, no cross-linking to
protein S5 was detected. There may be different explanations
for these discrepancies. For example, binding of the IRES
could block the access of the cross-linking reagent to protein
S5, or the protein lacks suitable targets for cross-linking. In
any case, the absence of the cross-link cannot indicate lack of
interaction, so our results as well as data of (10) do not exclude
possible interaction of protein S5 with domain II of HCV
IRES. At the same time, our cross-linking results indicate
that protein S5 is located also near hairpin IIIe. Thus, the
results obtained provide new details concerning the structural
organization of the HCV IRES 40S complex and give an idea
of the ribosomal area responsible for the initial binding of
HCV IRES (Figure 5b).
Our results conﬁrm the data (10) indicating that the 18S
rRNA is not determinant for HCV IRES binding to the 40S
subunit and are consistent with the suggestion made there that
important determinants for IRES binding are most likely
formed by amino acid sequences speciﬁc of mammalian
40S ribosomal proteins. The latter suggestion was based on
the inability of yeast 40S subunits to bind HCV IRES and on
large differences in amino acid sequences of the proteins
interacting with the IRES and their yeast counterparts.
All these data imply that the ability of the small ribosomal
subunits to bind HCV IRES appeared at late stages in evolu-
tion, whereas ribosomal sites operating during ‘classical’
translation, which are organized mainly by the rRNA
(rRNA is much more conserved as compared to ribosomal
proteins) were formed at early stages.
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